Foghorn Therapeutics (FHTX) EBT Margin Growth (1y) (2021 - 2026)
Foghorn Therapeutics (FHTX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Foghorn Therapeutics |
282.33 Mn |
193.42 Mn |
- |
-26,727.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-26,727.00 |
| Dec 31, 2025 |
44,317.00 |
| Sep 30, 2025 |
4,290.00 |
| Jun 30, 2025 |
8,499.00 |
| Mar 31, 2025 |
15,563.00 |
| Dec 31, 2024 |
-29,945.00 |
| Sep 30, 2024 |
-16,705.00 |
| Jun 30, 2024 |
17,621.00 |
| Mar 31, 2024 |
6,836.00 |
| Dec 31, 2023 |
30,696.00 |
| Sep 30, 2023 |
31,059.00 |
| Jun 30, 2023 |
9,848.00 |
| Mar 31, 2023 |
12,286.00 |
| Dec 31, 2022 |
330,793.00 |
| Sep 30, 2022 |
6.49 Mn |
| Jun 30, 2022 |
790,639.00 |
| Mar 31, 2022 |
757,076.00 |
| Dec 31, 2021 |
440,806.00 |
| Sep 30, 2021 |
-5.48 Mn |
